ICYMI: INZ-701 Begets Positive Data in Clinical Study on ABCC6 Deficiency and ENPP1 Deficiency
Biopharmaceutical company Inozyme Pharma ("Inozyme") has become a leader at the forefront of developing innovative therapies for rare diseases such as ENPP1 deficiency (the childhood form is known as generalized…